![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 14, 10861-10869, April 6, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the ¶ Zentrum fuer Molekulare Neurobiologie, Universitaet
Hamburg, Martinistrasse 52, D-20246 Hamburg, Germany and the
We have identified and characterized an
N-acetylgalactosamine-4-O-sulfotransferase
designated GalNAc-4-ST2 (GenBankTM accession number
AF332472) based on its homology to HNK-1 sulfotransferase (HNK-1 ST).
The cDNA predicts an open reading frame encoding a type II membrane
protein of 443 amino acids with a 12-amino acid cytoplasmic domain, a
23-amino acid transmembrane domain, and a 408-amino acid luminal domain
containing four potential N-linked glycosylation sites.
GalNAc-4-ST2 displays a high degree of amino acid sequence identity
with GalNAc-4-ST1 (46%), HNK-1 ST (23%), chondroitin
4-O-sulfotransferase-1 (C4ST-1) (27%), and chondroitin
4-O-sulfotransferase-2 (C4ST-2) (24%). GalNAc-4-ST2 transfers sulfate to the C-4 hydroxyl of terminal The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AF332472 and AF332473.
Molecular Cloning and Expression of an
N-Acetylgalactosamine-4-O-sulfotransferase That
Transfers Sulfate to Terminal and Non-terminal
1,4-Linked
N-Acetylgalactosamine*
§,
, and
Department of Pathology, Washington University School of
Medicine, St. Louis, Missouri 63110
1,4-linked GalNAc
in the sequence GalNAc-
1,4GlcNAc
-R found on N-linked oligosaccharides and nonterminal
1,4-linked GalNAc in chondroitin and dermatan. The translated region of GalNAc-4-ST2 is encoded by five
exons located on human chromosome 18q11.2. Northern blot analysis
reveals a 2.1-kilobase transcript. GalNAc-4-ST2 message is most highly
expressed in trachea and to a lesser extent in heart, liver, pancreas,
salivary gland, and testis. The I.M.A.G.E. cDNA clone 49547 contains a putative GalNAc-4-ST2 splice form with an open reading frame
encoding a protein of 358 amino acids that lacks the transmembrane
domain and the stem region. This form of GalNAc-4-ST2 is not retained
by transfected cells and is active against chondroitin but not terminal
1,4-linked GalNAc. Thus, as with GalNAc-4-ST1, sequences N-terminal
to the catalytic domain contribute to the specificity of GalNAc-4-ST2
toward terminal
1,4-linked GalNAc.
*
This work was supported by National Institutes of Health
Grant R01-DK41738 (to J. U. B.), by Deutsche Forschungsgemeinschaft Grant SCHAI85/15-1 (to M. S.), and by a German Academic Exchange Service (DAAD) postdoctoral fellowship (to G. X.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Zentrum fuer
Molekulare Neurobiologie, Universitaet Hamburg, Martinistrasse 52, 20246 Hamburg, Germany. Tel.: 49-40-42803-6246; Fax: 49-40-42803-6248; E-mail: melitta.schachner@zmnh.uni-hamburg.de.
This article has been cited by other articles:
![]() |
R. K. Boregowda, Y. Mi, H. Bu, and J. U. Baenziger Differential expression and enzymatic properties of GalNAc-4-sulfotransferase-1 and GalNAc-4-sulfotransferase-2 Glycobiology, December 1, 2005; 15(12): 1349 - 1358. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tiedemann, B. Olander, E. Eklund, L. Todorova, M. Bengtsson, M. Maccarana, G. Westergren-Thorsson, and A. Malmstrom Regulation of the chondroitin/dermatan fine structure by transforming growth factor-{beta}1 through effects on polymer-modifying enzymes Glycobiology, December 1, 2005; 15(12): 1277 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Raju and M. C. Dalakas Gene expression profile in the muscles of patients with inflammatory myopathies: effect of therapy with IVIg and biological validation of clinically relevant genes Brain, August 1, 2005; 128(8): 1887 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Woodworth, P. Pesheva, D. Fiete, and J. U. Baenziger Neuronal-specific Synthesis and Glycosylation of Tenascin-R J. Biol. Chem., March 12, 2004; 279(11): 10413 - 10421. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mikami, S. Mizumoto, N. Kago, H. Kitagawa, and K. Sugahara Specificities of Three Distinct Human Chondroitin/Dermatan N-Acetylgalactosamine 4-O-Sulfotransferases Demonstrated Using Partially Desulfated Dermatan Sulfate as an Acceptor: IMPLICATION OF DIFFERENTIAL ROLES IN DERMATAN SULFATE BIOSYNTHESIS J. Biol. Chem., September 19, 2003; 278(38): 36115 - 36127. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okuda, T. Sawada, H. Nakano, K. Matsubara, Y. Matsuda, M. Fukuta, and O. Habuchi Mouse N-Acetylgalactosamine 4-Sulfotransferases-1 and -2. Molecular Cloning, Expression, Chromosomal Mapping and Detection of Their Activity with GalNAc{beta}1-4GlcNAc{beta}1-octyl J. Biochem., July 1, 2003; 134(1): 111 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-G. Kang, M. R. Evers, G. Xia, J. U. Baenziger, and M. Schachner Molecular Cloning and Characterization of Chondroitin-4-O-sulfotransferase-3. A NOVEL MEMBER OF THE HNK-1 FAMILY OF SULFOTRANSFERASES J. Biol. Chem., September 13, 2002; 277(38): 34766 - 34772. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Evers, G. Xia, H.-G. Kang, M. Schachner, and J. U. Baenziger Molecular Cloning and Characterization of a Dermatan-specific N-Acetylgalactosamine 4-O-Sulfotransferase J. Biol. Chem., September 21, 2001; 276(39): 36344 - 36353. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |